Treatment of xanthelasma palpebrarum by argon laser photocoagulation

Farag, Mohamed Y; Husseiny, Mostafa A. El; Abdulla, Ahmad I; Hovaghimian, Dikran G

doi:10.4103/2090-0686.140627

Cited by 2 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As for argon laser, a complete resolution was achieved in 84% of cases, but the remaining 16% showed reduction in size only. 38 – 40 Single studies on diode and KTP lasers reported that 25% of cases treated with diode had over 60% clearance, whereas 97% of lesions treated with KTP were almost cleared after the final session. 43 , 44 …”

Section: Resultsmentioning

confidence: 99%

“…Thirty studies reported outcomes of laser therapies, including carbon dioxide (CO 2 ) (n = 11), [15][16][17][18][19][20][21][22][23][24][25] erbiumdoped yttrium aluminum garnet (Er:YAG) (n = 7), [26][27][28][29][30][31][32] neodymium-doped yttrium aluminum garnet (Nd:YAG; n = 6), 31,[33][34][35][36][37] argon (n = 4), 30,[38][39][40] pulsed dye (n = 2), 41,42 diode (n = 1), 43 and potassium titanyl phosphate (KTP) (n = 1) 44 lasers.…”

Section: Treatment Modalitiesmentioning

confidence: 99%

“…As for argon laser, a complete resolution was achieved in 84% of cases, but the remaining 16% showed reduction in size only. [38][39][40] Single studies on diode and KTP lasers reported that 25% of cases treated with diode had over 60% clearance, whereas 97% of lesions treated with KTP were almost cleared after the final session. 43,44 The total rates of dyspigmentation, scarring, and recurrence among laser therapies were determined for CO 2 (16%, 6%, and 10%, respectively), Er:YAG (11%, 2%, and 20%), Nd:YAG (9%, 7%, and 31%), argon (7%, 0%, and 21%), pulsed dye (7%, 0%, and 0%), diode (31%, n/a, and n/a), and KTP (3%, 0%, and 43%) lasers.…”

Section: Lasermentioning

confidence: 99%

“…43,44 The total rates of dyspigmentation, scarring, and recurrence among laser therapies were determined for CO 2 (16%, 6%, and 10%, respectively), Er:YAG (11%, 2%, and 20%), Nd:YAG (9%, 7%, and 31%), argon (7%, 0%, and 21%), pulsed dye (7%, 0%, and 0%), diode (31%, n/a, and n/a), and KTP (3%, 0%, and 43%) lasers. [26][27][28]30,40,44 (See table, Supplemental Digital Content 3, which displays the complications and recurrence rates among included studies http://links.lww. com/PRSGO/C548.)…”

Section: Lasermentioning

confidence: 99%

See 3 more Smart Citations

A Practical Review of the Management of Xanthelasma palpebrarum

Malekzadeh

Ormseth

Janis

2023

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background: Xanthelasma palpebrarum is the most common type of xanthomatous lesion. Various methods for treating Xanthelasma palpebrarum have been reported. We conducted a systematic review to evaluate the efficacy and associated complications of different treatment methods, and we summarized these findings as a practical review designed to be clinically useful, accessible, and impactful. Methods: The PubMed and Embase databases were searched to identify clinical studies that reported on outcomes and complications of different methods of Xanthelasma treatment. The electronic databases were searched from January 1990 to October 2022. Data on study characteristics, lesion clearance, complications, and recurrences were collected. Results: Forty-nine articles (including 1329 patients) were reviewed. The studies reported on surgical excision, laser modalities, electrosurgical techniques, chemical peeling, cryotherapy, and intralesional injection. The majority of studies were retrospective (69%) and single-arm (84%). Surgical excision combined with blepharoplasty and skin grafts showed excellent outcomes for large Xanthelasma. CO2 and erbium yttrium aluminum garnet (Er:YAG) were the most commonly studied lasers and showed more than 75% improvement in over 90% and 80% of patients, respectively. Comparative studies reported better efficacy for CO2 laser than both Er:YAG laser and 30%–50% trichloroacetic acid. Dyspigmentation was the most encountered complication. Conclusions: Different methods for the treatment of Xanthelasma palpebrarum have been reported in the literature, with moderate to excellent efficacy and safety profiles depending on the size and location of the lesion. Surgery is more appropriate for larger and deeper lesions, whereas laser and electrosurgical techniques can be used in smaller and more superficial contexts. Only a limited number of comparative studies have been conducted, and novel clinical trials are necessary to further augment appropriate treatment selection.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Treatment Modalitiesmentioning

confidence: 99%

Section: Lasermentioning

confidence: 99%

Section: Lasermentioning

confidence: 99%

See 2 more Smart Citations

A Practical Review of the Management of Xanthelasma palpebrarum

Malekzadeh

Ormseth

Janis

2023

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

show abstract

Quantitative assessment of xanthelasma palpebrarum treated by argon laser photocoagulation using ImageJ software

Salamah

Elsayed²

2022

Delta Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose The aim of this study was to evaluate the effect of argon laser photocoagulation on xanthelasma using ImageJ software. Patients and methods The study included 41 eyes of 23 patients (49 individual xanthelasmic lesions). All lesions were treated by a single session of argon laser photocoagulation. The lesions were assessed prelaser and postlaser using ImageJ software. Results All xanthelasmic lesions improved in height and color. The pretreatment mean height in ImageJ was 168.93±11.64 pixels, while the mean posttreatment height was 131±8.39 pixels (P<0.001). The color moderately improved in 24.4% of the cases and markedly improved in 68.3% of the cases. Conclusion Argon laser treatment of xanthelasma is a safe and effective treatment modality. This finding was documented using ImageJ software.

show abstract

Treatment of xanthelasma palpebrarum by argon laser photocoagulation

Cited by 2 publications

References 13 publications

A Practical Review of the Management of Xanthelasma palpebrarum

A Practical Review of the Management of Xanthelasma palpebrarum

Quantitative assessment of xanthelasma palpebrarum treated by argon laser photocoagulation using ImageJ software

Contact Info

Product

Resources

About